CN102861142B - 一种治疗肺炎的药物及其制剂的制备方法及质量控制方法 - Google Patents
一种治疗肺炎的药物及其制剂的制备方法及质量控制方法 Download PDFInfo
- Publication number
- CN102861142B CN102861142B CN201210327937.0A CN201210327937A CN102861142B CN 102861142 B CN102861142 B CN 102861142B CN 201210327937 A CN201210327937 A CN 201210327937A CN 102861142 B CN102861142 B CN 102861142B
- Authority
- CN
- China
- Prior art keywords
- solution
- methanol
- reference substance
- filter
- adds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 36
- 206010035664 Pneumonia Diseases 0.000 title claims abstract description 14
- 238000003908 quality control method Methods 0.000 title claims description 7
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 238000000034 method Methods 0.000 claims abstract description 70
- 239000003814 drug Substances 0.000 claims abstract description 46
- 239000000203 mixture Substances 0.000 claims abstract description 35
- 229940079593 drug Drugs 0.000 claims abstract description 30
- 238000000605 extraction Methods 0.000 claims abstract description 11
- 229930013930 alkaloid Natural products 0.000 claims abstract description 8
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 216
- 239000000243 solution Substances 0.000 claims description 140
- 238000012360 testing method Methods 0.000 claims description 72
- 239000000341 volatile oil Substances 0.000 claims description 69
- 239000000284 extract Substances 0.000 claims description 68
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 60
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 54
- 239000013558 reference substance Substances 0.000 claims description 52
- 239000012567 medical material Substances 0.000 claims description 45
- 239000008187 granular material Substances 0.000 claims description 42
- 239000007788 liquid Substances 0.000 claims description 40
- 235000019640 taste Nutrition 0.000 claims description 40
- 239000012467 final product Substances 0.000 claims description 37
- 239000000463 material Substances 0.000 claims description 34
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 32
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 32
- 239000000706 filtrate Substances 0.000 claims description 32
- 239000000047 product Substances 0.000 claims description 32
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 25
- 241000600550 Lagotis brevituba Species 0.000 claims description 25
- 241000984131 Lagotis clarkei Species 0.000 claims description 25
- 241000628997 Flos Species 0.000 claims description 24
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 24
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 20
- 239000011259 mixed solution Substances 0.000 claims description 20
- 239000000843 powder Substances 0.000 claims description 18
- 239000007924 injection Substances 0.000 claims description 17
- 238000002347 injection Methods 0.000 claims description 17
- 239000007921 spray Substances 0.000 claims description 17
- 150000001875 compounds Chemical class 0.000 claims description 16
- 239000012530 fluid Substances 0.000 claims description 16
- 239000003208 petroleum Substances 0.000 claims description 16
- 239000000741 silica gel Substances 0.000 claims description 16
- 229910002027 silica gel Inorganic materials 0.000 claims description 16
- 239000002904 solvent Substances 0.000 claims description 16
- 238000004809 thin layer chromatography Methods 0.000 claims description 16
- 229920000858 Cyclodextrin Polymers 0.000 claims description 15
- 239000001116 FEMA 4028 Substances 0.000 claims description 15
- 238000003556 assay Methods 0.000 claims description 15
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 claims description 15
- 235000011175 beta-cyclodextrine Nutrition 0.000 claims description 15
- 229960004853 betadex Drugs 0.000 claims description 15
- 238000004811 liquid chromatography Methods 0.000 claims description 15
- 238000011161 development Methods 0.000 claims description 14
- 238000003756 stirring Methods 0.000 claims description 14
- XUHJBXVYNBQQBD-UHFFFAOYSA-N mesaconitine Natural products COC1CC(O)C2(COC)CN(C)C3C(C(C45)(OC(C)=O)C(O)C6OC)C(OC)C2C31C4CC6(O)C5OC(=O)C1=CC=CC=C1 XUHJBXVYNBQQBD-UHFFFAOYSA-N 0.000 claims description 13
- XUHJBXVYNBQQBD-GQPWXMLZSA-N molport-002-525-145 Chemical compound O([C@H]1[C@]2(O)C[C@H]3[C@]45[C@@H]6[C@@H](OC)[C@H]([C@@]([C@H]31)(OC(C)=O)[C@@H](O)[C@@H]2OC)[C@H]4N(C)C[C@@]6([C@@H](C[C@@H]5OC)O)COC)C(=O)C1=CC=CC=C1 XUHJBXVYNBQQBD-GQPWXMLZSA-N 0.000 claims description 13
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 12
- 238000003810 ethyl acetate extraction Methods 0.000 claims description 12
- IAVUBSCVWHLRGE-UXEKTNMQSA-N (6e)-2,5-dihydroxy-6-[(e)-1-hydroxy-3-(4-hydroxyphenyl)prop-2-enylidene]-2,4-bis[(2s,3r,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]cyclohex-4-ene-1,3-dione Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C(C(C(O)([C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)C1=O)=O)=C(O)\C1=C(/O)\C=C\C1=CC=C(O)C=C1 IAVUBSCVWHLRGE-UXEKTNMQSA-N 0.000 claims description 10
- ZZMASNSDVDSYKO-UHFFFAOYSA-N hydroxysafflor yellow A Natural products OCC1OC(C(O)C(O)C1O)C2=C(O)C(O)(C3OC(CO)C(O)C(O)C3O)C(=O)C(=C2O)C(=O)C=Cc4ccc(O)cc4 ZZMASNSDVDSYKO-UHFFFAOYSA-N 0.000 claims description 10
- XFSBVAOIAHNAPC-XTHSEXKGSA-N 16-Ethyl-1alpha,6alpha,19beta-trimethoxy-4-(methoxymethyl)-aconitane-3alpha,8,10alpha,11,18alpha-pentol, 8-acetate 10-benzoate Chemical compound O([C@H]1[C@]2(O)C[C@H]3[C@@]45C6[C@@H]([C@@]([C@H]31)(OC(C)=O)[C@@H](O)[C@@H]2OC)[C@H](OC)[C@@H]4[C@]([C@@H](C[C@@H]5OC)O)(COC)CN6CC)C(=O)C1=CC=CC=C1 XFSBVAOIAHNAPC-XTHSEXKGSA-N 0.000 claims description 9
- XFSBVAOIAHNAPC-UHFFFAOYSA-N Aconitin Natural products CCN1CC(C(CC2OC)O)(COC)C3C(OC)C(C(C45)(OC(C)=O)C(O)C6OC)C1C32C4CC6(O)C5OC(=O)C1=CC=CC=C1 XFSBVAOIAHNAPC-UHFFFAOYSA-N 0.000 claims description 9
- DPMGVDIWDTYPMP-UHFFFAOYSA-N Hypaconitine Natural products COCC12CCC(OC)C3(CN(C)C1)C4CC5(O)C(OC)C(O)C(CC(OC)C23)(OC(=O)C)C4C5OC(=O)c6ccccc6 DPMGVDIWDTYPMP-UHFFFAOYSA-N 0.000 claims description 9
- 229940039750 aconitine Drugs 0.000 claims description 9
- STDXGNLCJACLFY-UHFFFAOYSA-N aconitine Natural products CCN1CC2(COC)C(O)CC(O)C34C5CC6(O)C(OC)C(O)C(OC(=O)C)(C5C6OC(=O)c7ccccc7)C(C(OC)C23)C14 STDXGNLCJACLFY-UHFFFAOYSA-N 0.000 claims description 9
- -1 ester alkaloid Chemical class 0.000 claims description 9
- 239000000945 filler Substances 0.000 claims description 9
- FIDOCHXHMJHKRW-GKVQVCCJSA-N hypaconitine Chemical compound O([C@H]1[C@]2(O)C[C@H]3[C@]45[C@@H](OC)CC[C@@]6([C@H]4[C@@H](OC)[C@H]([C@@](OC(C)=O)([C@H]31)[C@@H](O)[C@H]2OC)[C@H]5N(C)C6)COC)C(=O)C1=CC=CC=C1 FIDOCHXHMJHKRW-GKVQVCCJSA-N 0.000 claims description 9
- 238000010992 reflux Methods 0.000 claims description 9
- 238000001256 steam distillation Methods 0.000 claims description 9
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 8
- OYOSOPYTYFQFJM-UHFFFAOYSA-N CO.C(=O)OCC.C(Cl)(Cl)Cl Chemical compound CO.C(=O)OCC.C(Cl)(Cl)Cl OYOSOPYTYFQFJM-UHFFFAOYSA-N 0.000 claims description 8
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 8
- 229960000583 acetic acid Drugs 0.000 claims description 8
- 238000010828 elution Methods 0.000 claims description 8
- 238000001914 filtration Methods 0.000 claims description 8
- 239000012362 glacial acetic acid Substances 0.000 claims description 8
- YTJSFYQNRXLOIC-UHFFFAOYSA-N octadecylsilane Chemical compound CCCCCCCCCCCCCCCCCC[SiH3] YTJSFYQNRXLOIC-UHFFFAOYSA-N 0.000 claims description 8
- 239000000377 silicon dioxide Substances 0.000 claims description 8
- 239000007864 aqueous solution Substances 0.000 claims description 7
- 239000002552 dosage form Substances 0.000 claims description 6
- 238000001556 precipitation Methods 0.000 claims description 6
- 239000002775 capsule Substances 0.000 claims description 5
- BHQCQFFYRZLCQQ-UHFFFAOYSA-N (3alpha,5alpha,7alpha,12alpha)-3,7,12-trihydroxy-cholan-24-oic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 BHQCQFFYRZLCQQ-UHFFFAOYSA-N 0.000 claims description 4
- 239000004380 Cholic acid Substances 0.000 claims description 4
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 4
- 235000019257 ammonium acetate Nutrition 0.000 claims description 4
- 229930014669 anthocyanidin Natural products 0.000 claims description 4
- 150000001452 anthocyanidin derivatives Chemical class 0.000 claims description 4
- 235000008758 anthocyanidins Nutrition 0.000 claims description 4
- 229940046011 buccal tablet Drugs 0.000 claims description 4
- 239000006189 buccal tablet Substances 0.000 claims description 4
- BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 claims description 4
- 235000019416 cholic acid Nutrition 0.000 claims description 4
- 229960002471 cholic acid Drugs 0.000 claims description 4
- KXGVEGMKQFWNSR-UHFFFAOYSA-N deoxycholic acid Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 KXGVEGMKQFWNSR-UHFFFAOYSA-N 0.000 claims description 4
- OAYLNYINCPYISS-UHFFFAOYSA-N ethyl acetate;hexane Chemical compound CCCCCC.CCOC(C)=O OAYLNYINCPYISS-UHFFFAOYSA-N 0.000 claims description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 4
- 229940023488 pill Drugs 0.000 claims description 4
- 239000006187 pill Substances 0.000 claims description 4
- 239000003826 tablet Substances 0.000 claims description 3
- 239000006196 drop Substances 0.000 claims description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims 1
- 239000002245 particle Substances 0.000 abstract description 15
- 238000005516 engineering process Methods 0.000 abstract description 6
- 238000009472 formulation Methods 0.000 abstract description 6
- 238000011160 research Methods 0.000 abstract description 4
- 150000003797 alkaloid derivatives Chemical class 0.000 abstract 1
- 230000007012 clinical effect Effects 0.000 abstract 1
- 238000011031 large-scale manufacturing process Methods 0.000 abstract 1
- 238000010998 test method Methods 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 description 18
- 238000004128 high performance liquid chromatography Methods 0.000 description 11
- 229920001353 Dextrin Polymers 0.000 description 6
- 239000004375 Dextrin Substances 0.000 description 6
- 235000019425 dextrin Nutrition 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 238000003809 water extraction Methods 0.000 description 6
- 206010011224 Cough Diseases 0.000 description 5
- 229930006000 Sucrose Natural products 0.000 description 5
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 5
- 238000009835 boiling Methods 0.000 description 5
- 239000000084 colloidal system Substances 0.000 description 5
- 238000002481 ethanol extraction Methods 0.000 description 5
- 239000000446 fuel Substances 0.000 description 5
- 239000005720 sucrose Substances 0.000 description 5
- 239000002671 adjuvant Substances 0.000 description 4
- 238000004806 packaging method and process Methods 0.000 description 4
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 3
- 244000303040 Glycyrrhiza glabra Species 0.000 description 3
- HTOBCWQYHHELFE-UHFFFAOYSA-N acetonitrile oxolane Chemical compound O1CCCC1.O1CCCC1.C(C)#N HTOBCWQYHHELFE-UHFFFAOYSA-N 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 3
- 235000011477 liquorice Nutrition 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 238000005550 wet granulation Methods 0.000 description 3
- 206010008479 Chest Pain Diseases 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 238000007922 dissolution test Methods 0.000 description 2
- 239000003172 expectorant agent Substances 0.000 description 2
- 230000003419 expectorant effect Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 230000029058 respiratory gaseous exchange Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 238000001291 vacuum drying Methods 0.000 description 2
- 241000227129 Aconitum Species 0.000 description 1
- 201000001178 Bacterial Pneumonia Diseases 0.000 description 1
- 206010004542 Bezoar Diseases 0.000 description 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 1
- 244000020518 Carthamus tinctorius Species 0.000 description 1
- 241000711573 Coronaviridae Species 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 208000035109 Pneumococcal Infections Diseases 0.000 description 1
- 206010035737 Pneumonia viral Diseases 0.000 description 1
- 201000003176 Severe Acute Respiratory Syndrome Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 229940121657 clinical drug Drugs 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000007877 drug screening Methods 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 208000009421 viral pneumonia Diseases 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
时间(min) | 流动相A(%) | 流动相B(%) |
0 | 15 | 85 |
60 | 35 | 65 |
提取方法 | 羟基红花黄色素A转移率(%) | 红景天苷转移率(%) |
水提取 | 85 | 86 |
30%乙醇提取 | 87 | 87 |
60%乙醇提取 | 86 | 89 |
制粒工艺 | 羟基红花黄色素A损失率(%) | 红景天苷损失率(%) |
一步制粒 | 1.6 | 2.1 |
湿法制粒 | 13.8 | 7.5 |
时间(min) | 流动相A(%) | 流动相B(%) |
0 | 15 | 85 |
60 | 35 | 65 |
时间(min) | 流动相A(%) | 流动相B(%) |
0 | 15 | 85 |
60 | 35 | 65 |
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210327937.0A CN102861142B (zh) | 2012-09-07 | 2012-09-07 | 一种治疗肺炎的药物及其制剂的制备方法及质量控制方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210327937.0A CN102861142B (zh) | 2012-09-07 | 2012-09-07 | 一种治疗肺炎的药物及其制剂的制备方法及质量控制方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102861142A CN102861142A (zh) | 2013-01-09 |
CN102861142B true CN102861142B (zh) | 2015-06-03 |
Family
ID=47440458
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210327937.0A Expired - Fee Related CN102861142B (zh) | 2012-09-07 | 2012-09-07 | 一种治疗肺炎的药物及其制剂的制备方法及质量控制方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102861142B (zh) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1365716A (zh) * | 2001-01-15 | 2002-08-28 | 杨孟君 | 纳米九味石灰华制剂药物及其制备方法 |
CN102198230A (zh) * | 2010-03-24 | 2011-09-28 | 胡清文 | 一种用于治疗小儿反复感冒的药物制剂及其制备方法 |
CN102579861B (zh) * | 2011-01-17 | 2014-11-05 | 山东阿如拉药物研究开发有限公司 | 一种安儿宁颗粒的检测方法 |
CN102526536B (zh) * | 2012-03-14 | 2013-07-24 | 山东阿如拉药物研究开发有限公司 | 一种药物组合物安儿宁含片及其制备方法和应用 |
-
2012
- 2012-09-07 CN CN201210327937.0A patent/CN102861142B/zh not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN102861142A (zh) | 2013-01-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102861255B (zh) | 一种治疗流感的药物及其制剂的制备方法及质量控制方法 | |
CN101569712B (zh) | 一种治疗感冒风寒的中药组合物 | |
CN101366876A (zh) | 一种治疗咽喉肿痛的中药制剂及其制备方法 | |
CN104224813B (zh) | 一种药物组合物及其制备方法与用途 | |
CN102920964B (zh) | 一种治疗咳嗽的中药制剂 | |
CN102697935A (zh) | 一种防治鸭瘟病的中药颗粒剂及其制备方法 | |
CN102908519B (zh) | 一种治疗流感的药物及其制剂的制备方法及质量检测方法 | |
CN101757374B (zh) | 一种制备治疗烧烫伤的药剂及其制备方法 | |
CN104940781A (zh) | 一种用于治疗白脉病的藏药组合物及其制备方法 | |
CN102526574A (zh) | 一种六味安消丸中药制剂及其制备方法 | |
CN106420919A (zh) | 一种大苞荆芥总黄酮提取物的制备方法和用途 | |
CN102861142B (zh) | 一种治疗肺炎的药物及其制剂的制备方法及质量控制方法 | |
CN101642492B (zh) | 治疗慢性盆腔炎的药物及其制备方法 | |
CN102078474B (zh) | 纳米四季感冒分散片及其制备方法 | |
CN111358906B (zh) | 一种适用于外感症的中药组合物 | |
CN101147767B (zh) | 一种治疗痤疮的药物组合物胶囊剂的制备方法 | |
CN103908631A (zh) | 一种具有抗乳腺增生作用的中药复方提取物及其制备方法 | |
CN103230433B (zh) | 益心巴迪然吉布亚颗粒的制备方法 | |
CN102727651B (zh) | 一种牛黄上清胶囊的制备方法及其质量检测方法 | |
CN102631386B (zh) | 柴胡解热镇痛制剂及其制备工艺 | |
CN102240328B (zh) | 一种治疗感冒的中药及其制备方法 | |
CN1961943A (zh) | 一种治疗感冒的药物组合物及其制备方法和质量控制方法 | |
CN108042682A (zh) | 一种滋水清肝丸及其制备方法 | |
CN111249421B (zh) | 一种治疗湿热性外感热病初起的中药制剂及其制备方法和用途 | |
CN103768494B (zh) | 一种治疗偏头痛的药物组合物及其制备方法和应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: TAISHAN HOSPITAL Free format text: FORMER OWNER: JINAN XINGYI MEDICAL TECHNOLOGY CO., LTD. Effective date: 20150508 |
|
C41 | Transfer of patent application or patent right or utility model | ||
C53 | Correction of patent for invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Han Junfen Inventor after: Cao Mingliang Inventor after: Li Hongshuang Inventor after: Xia Chengcai Inventor before: Shao Chengming |
|
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 250101 JINAN, SHANDONG PROVINCE TO: 271016 TAIAN, SHANDONG PROVINCE Free format text: CORRECT: INVENTOR; FROM: SHAO CHENGMING TO: HAN JUNFEN CAO MINGLIANG LI HONGSHUANG XIA CHENGCAI |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20150508 Address after: 271016 the Great Wall Road, Shandong, Tai'an, No. 619 Applicant after: Taishan Hospital Address before: 250101 No. 51 Industrial South Road, Shandong, Ji'nan Applicant before: Jinan Xingyi Medical Technology Co.,Ltd. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150603 Termination date: 20180907 |
|
CF01 | Termination of patent right due to non-payment of annual fee |